00:00Eli Lilly announced a $6.5 billion investment to build a new manufacturing facility in Houston focused on small molecule drugs, including its new experimental obesity pill.
00:12It's part of a broader $27 billion U.S. expansion plan to build four new U.S. plants aimed at increasing drug production capability amid surging demand and potential import tariffs.
00:24The Houston location, expected to create over 4,600 jobs, will be key to producing oral treatments across obesity, diabetes, oncology, and more.
Comments